Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2005
08/17/2005CN1215052C Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products
08/17/2005CN1214816C Process and materials for the rapid detection of i(streptococcus pneumoniae) employing purified antigen-specific antibodies
08/17/2005CN1214803C Chinese herbal medicine for treating No.5 diseaze of livestock and its usage
08/17/2005CN1214798C Nocar ointment for treating herpes simplex and herpes zoster
08/17/2005CN1214792C Highly absorbable solid preparation
08/17/2005CN1214790C Method for preparing isoxazole substituted composition for treating inflammation
08/16/2005US6930123 Benz(f)indole compounds useful for Inflammatory Diseases
08/16/2005US6930117 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
08/16/2005US6930116 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals
08/16/2005US6930106 Inhibitors of HCV NS5B polymerase
08/16/2005US6930097 Matrix metalloproteinase and tumor necrosis factor inhibitors
08/16/2005US6930092 Antibiotic agents
08/16/2005US6930085 G-type peptides to ameliorate atherosclerosis
08/16/2005US6929955 Interactive system for presenting and eliminating substances
08/16/2005US6929930 Nucleotide sequences coding antigenic peptide for use in diagnosis of bacterial infections
08/16/2005US6929818 Methods and clinical devices for the inhibition or prevention of mammalian cell growth
08/16/2005US6929808 Isolating modulators of amyloid expression; obtain plant, extract proteins, incubate with chromatographic column, elute, recover preferential protein
08/16/2005US6929798 Compositions and methods for treatment of microbial infections
08/16/2005US6929794 IL-12 as an adjuvant for Bordetella pertussis vaccines
08/16/2005CA2342974C Methods and compositions for inhibition of angiogenesis
08/16/2005CA2334344C Method and composition for the treatment of epidermal irritations and infections
08/16/2005CA2238521C Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
08/16/2005CA2224257C Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
08/11/2005WO2005072763A1 Liver fibrosis inhibitor
08/11/2005WO2005072690A1 Antimicrobial oral rinse solid composition
08/11/2005WO2005041858A3 Mucin production inhibitor
08/11/2005US20050176964 Nicotinamide derivatives useful as p38 inhibitors
08/11/2005US20050176955 N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as hiv integrase inhibitors
08/11/2005US20050176941 Nucleoside analogues whose sugar moieties are bound in s-form and oligonucleotide derivatives comprising nucleotide analogues thereof
08/11/2005US20050176938 Anhydrate/hydrate of an erythromycin derivative and processes for preparing said anhydrate/hydrate
08/11/2005US20050176930 Nucleotide sequences coding tumor associated antigen for use in diagnosis, prevention and treatment of cell proliferative disorders; mimetics; antitumor agents
08/11/2005US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis
08/11/2005US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation
08/11/2005US20050176820 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids
08/11/2005US20050176817 Anticancer agents; prevention of infections; autoimmune diseases;antiarthritic agents; cystic fibrosis
08/11/2005US20050176816 Controlling infections; antiallergens; antiarthritic agents; cardiovascular disorders
08/11/2005US20050176815 Malaria therapy
08/11/2005US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde
08/11/2005US20050176801 Acyl bicyclic derivatives of pyrrol
08/11/2005US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
08/11/2005US20050176779 dioxodihydropyridine derivatives and certain methacrylic acid and furan derivative precursors thereof; use as tumor growth inhibitors and anti-cancer agents, antibiotics and/or antiviral agents
08/11/2005US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them
08/11/2005US20050176766 2,3-Oxidosqualene-lanosterol cyclase inhibitors
08/11/2005US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders
08/11/2005US20050176758 2-(hydroxy or methoxymethoxy)-4-(carboxy or alkoxycarbonyl)-5-(fluoro or hydrogen)-7-oxabicyclo(4.1.0)hept-3-ene chemical intermediates to neuraminidase inhibitors
08/11/2005US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted
08/11/2005US20050176752 Such as 2,2,4-trimethyl-1,3-dioxolo[4,5-c]piperidin-7-ol; reacting methanesulfonic acid 6-hydroxy-2,2,6-trimethyl-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl ester with phthalimide; avoids the use of reagents such as corrosive triflic anhydride and toxic sodium azide; intermediates to antivirals
08/11/2005US20050176723 (Halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
08/11/2005US20050176718 Aza- and polyaza-naphthalenyl carboxamides useful as HIV integrase inhibitors
08/11/2005US20050176714 Pyridazine derivatives
08/11/2005US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity
08/11/2005US20050176701 Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same
08/11/2005US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof
08/11/2005US20050176697 crystal of 3-[4-(1-methyl-4-pyridinio)-2-thiazolylthio]-7 beta -[2-(5-phosphonoamino-1,2,4-thiadiazol-3-yl)-2(Z)-ethoxyiminoacetamido]-3-cephem-4-carboxylate with acetic acid and water, crystals; anti-Methicillin Resistant Staphylococcus aureus agent; storage stability, high purity
08/11/2005US20050176694 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity
08/11/2005US20050176673 guanin-9-yl, adenin-9-yl, 2,6-diaminopurin-9-yl, 2-aminopurin-9-yl or their 1-deaza, 3-deaza, or 8-aza compounds, or cytosin-1-yl - ethoxymethanephosphonic acid derivatives, used to treat osteoporosis and other disorders of bone metabolism, cancer, or viral infections
08/11/2005US20050176661 Antiviral oligonucleotides
08/11/2005US20050176655 Novel macrolide derivatives havaing effect of potentiating antifungal activity
08/11/2005US20050176653 Cultivating a Amycolatopsis orientalis strain under aerobic conditions, chemically modifying the product; antibiotics; anticarcinogenic agent, antiinflammatory agent
08/11/2005US20050176648 oligopeptide including enantiomers, stereoisomers and tautomers, used as hepatitis c protease enzyme inhibitors for prophylaxis or prevention of viral diseases
08/11/2005US20050176631 Method for reducing morbidity and mortality in critically ill patients
08/11/2005US20050176130 Functional mutations in respiratory syncytial virus
08/11/2005US20050176123 Protease inhibitor
08/11/2005US20050176094 Polypeptide having immunomodulatory activity, antiviral activity, and antitumor activity; polynucleotides, expression vectors , probes and antibodies; predicting responsiveness to treatment with interferon- alpha and other interferons which act at the Type 1 interferon receptor
08/11/2005US20050176077 Using urease as tool in identifying modulators of bacterial propagation; enzyme inhibitors
08/11/2005US20050176060 Crystal structure
08/11/2005US20050175985 Cold-adapted equine influenza viruses
08/11/2005US20050175724 Composition for modulating at least one physiological reaction or inducing an immune response in human or animal after oral administration; for intestinal delivery of a physiologically active agent, a neutralizing agent, an inhibitor of digestive enzymes, an uptake increasing agent; synergistic
08/11/2005US20050175694 Long acting compositions comprising zidovudine and lamivudine
08/11/2005US20050175644 Preparation for oxidation-sensitive compounds and method for making same
08/11/2005US20050175641 Homogenous liquid blend of hydrophilic polyvinyl alcohol, hydroxypropylmethyl cellulose, hydroxypropyl cellulose , polyvinyl pyrollidone, carbomer, maleic anhydride-methyl vinyl ether decadiene cross polymer and/or hydroxypropylguar; and hydrophobic ethyl cellulose; anti-onychomycoses agents; acne
08/11/2005US20050175635 Method and composition
08/11/2005US20050175633 Polynucleic acids isolated from a porcine reproductive and respiratory syndrome virus (PRRSV), proteins encoded by the polynucleic acids, vaccines based on the proteins and/or polynucleic acids, a method of protecting a pig from a PRRSV and a method of detecting a PRRSV
08/11/2005US20050175632 Vaccine for preventing cervical cancer
08/11/2005US20050175629 Helicobacter pylori vaccination
08/11/2005US20050175621 Adjuvant composition comprising FHA protein or a fragment of FHA protein in its free form
08/11/2005US20050175597 For easy administration and storage stability
08/11/2005US20050175580 Compositions and methods for enhancing cytokine activity and treating hypotension associated with the administration of cytokines
08/11/2005US20050175550 Trifluoromethionine for preventing and/or treating intraoral diseases; bad breath, periodontal disease, alveolar pyorrhea; bactericide
08/11/2005CA2774961A1 Oral care compositions comprising increased bioavailable levels of quaternary ammonium antimicrobials
08/11/2005CA2554733A1 Method for producing sorbicillactone a
08/11/2005CA2554410A1 Biotherapeutics, diagnostics and research reagents
08/11/2005CA2554245A1 Novel hiv protease inhibitors
08/11/2005CA2554201A1 Compositions and use of tyrosine kinase inhibitors to treat pathogenic infection
08/11/2005CA2553670A1 Anti-viral therapeutics
08/11/2005CA2553455A1 Use of adefovir or tenofovir for inhibiting mmtv-like viruses involved in breast cancer and primary biliary cirrhosis
08/11/2005CA2553089A1 Novel piperidines as chemokine modulators (ccr)
08/11/2005CA2552317A1 Hcv ns-3 serine protease inhibitors
08/10/2005EP1561815A2 Tissue-specific and target rna-specific ribozymes
08/10/2005EP1561744A2 Amine derivatives, process for producing the same and their use as antimycotic agent
08/10/2005EP1561465A2 Methods of use of fluoroquinolone compounds against bacteria
08/10/2005EP1561463A2 Benzamidoxime prodrugs as antipneumocystic agents
08/10/2005EP1560855A1 Polysaccharide of echinacea angustifolia
08/10/2005EP1560845A1 Vaccine against hcv
08/10/2005EP1560844A1 Hepatitis c vaccine
08/10/2005EP1560827A1 Anti-infective agents
08/10/2005EP1560818A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use
08/10/2005EP1560589A1 Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives
08/10/2005EP1560584A2 Fab i inhibitors
08/10/2005EP1560573A2 Therapeutic agents and corresponding treatments
1 ... 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 967 ... 1798